Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors.

Circulation Research
Matthew R FlemingJavid Moslehi

Abstract

Novel targeted cancer therapies have revolutionized oncology therapies, but these treatments can have cardiovascular complications, which include heterogeneous cardiac, metabolic, and vascular sequelae. Vascular side effects have emerged as important considerations in both cancer patients undergoing active treatment and cancer survivors. Here, we provide an overview of vascular effects of cancer therapies, focusing on small-molecule kinase inhibitors and specifically inhibitors of BTK (Bruton tyrosine kinase), which have revolutionized treatment and prognosis for B-cell malignancies. Cardiovascular side effects of BTK inhibitors include atrial fibrillation, increased risk of bleeding, and hypertension, with the former 2 especially providing a treatment challenge for the clinician. Cardiovascular complications of small-molecule kinase inhibitors can occur through either on-target (targeting intended target kinase) or off-target kinase inhibition. We will review these concepts and focus on the case of BTK inhibitors, highlight the emerging data suggesting an off-target effect that may provide insights into development of arrhythmias, specifically atrial fibrillation. We believe that cardiac and vascular sequelae of novel targeted...Continue Reading

References

Sep 1, 1995·Immunity·W N KhanL A Herzenberg
Oct 21, 1998·Current Biology : CB·L S QuekS P Watson
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·David A FrumanOwen N Witte
May 2, 2002·Nature Medicine·Steven A CroneKuo-Fee Lee
Dec 10, 2002·Science·G ManningS Sudarsanam
Jul 5, 2003·Blood·Ben T AtkinsonSteve P Watson
Jun 17, 2004·Circulation·Stefano BellostaAlberto Corsini
Feb 8, 2006·Journal of Thrombosis and Haemostasis : JTH·J W BlomF R Rosendaal
Apr 25, 2006·Cellular and Molecular Neurobiology·Eric M SmithThomas K Hughes
Dec 21, 2006·Clinical Pharmacology and Therapeutics·Pertti J NeuvonenJanne T Backman
Jan 4, 2008·The New England Journal of Medicine·Michel AziziStéphane Oudard
Aug 14, 2008·Nature Reviews. Molecular Cell Biology·Tommer Ravid, Mark Hochstrasser
Nov 30, 2010·Cell·Philip Cohen, Marianna Tcherpakov
Dec 2, 2010·Nature Reviews. Drug Discovery·Friedrich GrimmingerHossein A Ghofrani
May 10, 2011·Annual Review of Biochemistry·Arvin C Dar, Kevan M Shokat
Aug 5, 2011·Journal of the National Cancer Institute·Philipp Le CoutrePeter Valent
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ranjana H AdvaniNathan H Fowler
Nov 10, 2012·International Journal of Biological Sciences·Masato Okada
Feb 27, 2013·Chemistry & Biology·Qingsong LiuNathanael S Gray
Mar 15, 2013·The New England Journal of Medicine·Javid Moslehi
May 24, 2013·Clinical Pharmacology and Therapeutics·S A ScottUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Nov 5, 2013·The New England Journal of Medicine·J E CortesUNKNOWN PACE Investigators
Nov 5, 2013·The New England Journal of Medicine·John D GroarkeJavid Moslehi
Jun 3, 2014·The New England Journal of Medicine·John C ByrdUNKNOWN RESONATE Investigators
Aug 2, 2014·Haematologica·Jacob P LaubachPaul G Richardson
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Apr 9, 2015·The New England Journal of Medicine·Steven P TreonRanjana H Advani
May 16, 2015·Trends in Pharmacological Sciences·Peng WuMads H Clausen
Sep 5, 2015·Journal of the American College of Cardiology·Weijuan LiJavid Moslehi
Sep 12, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Alexander P ByeJonathan M Gibbins
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javid J Moslehi, Michael Deininger
Nov 4, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski

❮ Previous
Next ❯

Citations

Jun 11, 2021·Circulation Research·Nicholas J Leeper, Naomi M Hamburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.